Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Unionman Technology Co.,Ltd.
688609
5
Shenzhen Tianyuan Dic Information Technology
300047
CN Stock MarketDetailed Quotes
002100 Tecon Biology Co.Ltd
- 6.38
- +0.03+0.47%
Trading May 6 10:26 CST
8.71BMarket Cap12.46P/E (TTM)
6.43High6.35Low157.84KlotVolume6.41Open6.35Pre Close100.60MTurnover1.16%Turnover Ratio14.40P/E (Static)1.37BShares8.7952wk High1.22P/B8.71BFloat Cap5.6752wk Low6.99Limit Up1.37BShs Float19.02Historical High5.72Limit Down1.26%Amplitude-0.32Historical Low--Dividend TTM6.37Avg Price81.91KlotAsk--Div YieldTTM100Lot Size73.90KlotBid
Tecon Biology Co.Ltd News
Tiankang Biotech: Announcement on the 2024 Profit Distribution Plan
Tiankang Biotech: Notice on the judicial freezing of company shares held by shareholders holding 5% or more of the shares
Tiankang Biotech: Announcement on the progress of the controlling shareholder\'s plan to increase the company\'s shares by more than half of the time
Tiankang Biotech: Announcement on the progress of the controlling shareholder\'s increase in the company\'s shares
Tiankang Biotech: Announcement on the controlling shareholder increasing the company\'s shares to 1%
Tiankang Biotech: Announcement on the progress of the controlling shareholder increasing the company\'s shares for the first time
Tiankang Biotech: Announcement on the controlling shareholder\'s plan to increase the company\'s share holdings and receiving loan support to increase capital holdings
Tecon Biology Co.Ltd: Announcement on the 2023 Profit Distribution Plan
Tiankang Biotech: Announcement on the completion of the controlling shareholder\'s plan to increase the company\'s shares
Tiankang Biotech: Announcement on the progress of the controlling shareholder\'s plan to increase the company\'s shares by half of the time
Tiankang Biotech: 2022 Annual Equity Distribution Implementation Notice
Tiankang Biotech: Announcement on Tiankang debt-to-share price adjustments
Tiankang Biotech: CITIC Construction Investment Securities Co., Ltd.\'s Sponsorship Summary Report on Tiankang Biotech\'s Non-public Offering of Shares
Tiankang Biotech: Announcement on the extension of the plan of the controlling shareholder, Xinjiang Production and Construction Corps State-owned Assets Management Co., Ltd., to increase the company\'s shares
Tiankang Biotech: Announcement on the Settlement of Some Non-public Stock Fundraising Projects and Permanently Supplementing Liquidity with Savings Raised
Tiankang Biotech: CITIC Construction Investment Securities Co., Ltd.\'s inspection opinion on the conclusion of Tiankang Biotech\'s non-public stock fundraising project and permanently replenishing working capital from savings raised
Tiankang Biotech: Announcement on 2022 Profit Distribution Plan
Tiankang Biotech: Notice on Unfreezing Company Shares Held by Shareholders Holding 5% or More
Tiankang Biotech: Announcement on the progress of the controlling shareholder's plan to increase the company's shares by half of the time
Tiankang Biotech: Announcement on the controlling shareholder's increase in the company's shares and subsequent plans to increase its holdings
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting